| Name | Title | Contact Details |
|---|
Jack Link`s Protein Snacks is a global leader in snacking and the No. 1 meat snack manufacturer worldwide. Still family-owned with headquarters in Minong, Wisconsin, Jack Link`s also has a large corporate hub in Downtown Minneapolis, Minnesota, and operates a total of 11 manufacturing and distribution facilities in four countries. Jack Link`s produces high-quality, great-tasting protein snacks that feed the wild sides of consumers around the world. Jack Link`s Protein Snacks family of brands includes Jack Link`s, Lorissa`s Kitchen, MATADOR, SQUATCH, World Kitchens Jerky, Grass Run Farms Meat Snacks, Bifi and Pepperami.
SYNQ3 Restaurant Solutions is a global restaurant ordering solutions provider specializing in GROWING SALES! We are a management team that has worked with some of the largest and fastest growing restaurant brands in the world. Our experience in the business of convenience and restaurant ordering solutions is unparalleled in terms of both process and execution. Our technical capability is unmatched in the industry.
"Its what real chicken tastes like"
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.